Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
2025 · 4th Quarter (Oct 1 - Dec 31)
HIKMA PHARMACEUTICALS USA INC.
Filed by APCO WORLDWIDE LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 15, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- APCO WORLDWIDE LLC
- Filing UUID
- d018c016-62d1-4a72-a2ea-f3156a7c51f8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Trade policies impacting domestic generic pharmaceutical manufacturing
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.